Skip to main content

Table 1 Case Reports/Series of Ipilimumab-Associated Neurological irAEs

From: Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Case reports/series

Neurological manifestations

Presence of additional irAEs

Wilgenhof S, et al. (2011) [23]

Guillain-Barré Syndrome

None reported

Bompaire F, et al. (2012) [18]

Meningo-radiculo-neuritis

None reported

Bot I, et al. (2013) [21]

(n = 3)

Hypophysitis

Meningitis

Guillain-Barré syndrome

 

Liao B. et al. (2014) [21]

(n = 3)

CIDP

Transverse myelitis

Myasthenia gravis-type syndrome

None reported

Johnson DB, et al. (2015) [24]

Myasthenia gravis

Thyroiditis

Dermatitis

Thaipisuttikul I, et al.(2015) [35]

Peripheral neuropathy

None reported

Abdallah AO, et al. (2016) [31]

Necrotic myelopathy

None reported

Chen JH, et al. (2017) [27]

Myasthenia gravis

Myositis

Polyneuropathy

Hepatitis

Derle E, et al. (2018) [25]

Myasthenia gravis

None reported

Montes V, et al. (2018) [26]

Myasthenia gravis

None reported

Naito T, et al. (2018) [22]

Acute cerebellitis

None reported

Ruff MW, et al. (2018) [28]

(n = 2)

Bilateral phrenic nerve paralysis

Bell’s palsy

Pan-hypopituitarism